Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker KYNB
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 6, 2026 | KYNB Kyntra Bio, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Oct 1, 2026 | KYNB Kyntra Bio, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 31, 2026 | KYNB Kyntra Bio, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 31, 2026 | KYNB Kyntra Bio, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Aug 31, 2026 | KYNB Kyntra Bio, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 13, 2026 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 16, 2026 | KYNB Kyntra Bio, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 9, 2026 | KYNB Kyntra Bio, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 11, 2026 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 9, 2026 | KYNB Kyntra Bio, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Mar 16, 2026 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 7, 2026 | KYNB Kyntra Bio, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 7, 2026 | KYNB Kyntra Bio, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 10, 2025 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 6, 2025 | KYNB Kyntra Bio, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 5, 2025 | KYNB Kyntra Bio, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Sep 2, 2025 | KYNB Kyntra Bio, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 18, 2025 | KYNB Kyntra Bio, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 14, 2025 | KYNB Kyntra Bio, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 11, 2025 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 14, 2025 | KYNB Kyntra Bio, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 13, 2025 | KYNB Kyntra Bio, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 12, 2025 | KYNB Kyntra Bio, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jun 12, 2025 | KYNB Kyntra Bio, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Jun 9, 2025 | KYNB Kyntra Bio, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 9, 2025 | KYNB Kyntra Bio, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 9, 2025 | KYNB Kyntra Bio, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 12, 2025 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 4, 2025 | KYNB Kyntra Bio, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 31, 2025 | KYNB Kyntra Bio, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 28, 2025 | KYNB Kyntra Bio, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 17, 2025 | KYNB Kyntra Bio, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Mar 17, 2025 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 24, 2025 | KYNB Kyntra Bio, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 20, 2025 | KYNB Kyntra Bio, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 20, 2025 | KYNB Kyntra Bio, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 20, 2025 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 20, 2025 | KYNB Kyntra Bio, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 16, 2024 | KYNB Kyntra Bio, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 12, 2024 | KYNB Kyntra Bio, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
40 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:32 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances